跳至主要内容
临床试验/KCT0004847
KCT0004847已完成未知

Multi-protein Assessment using Serum to deTermine the breast lesion malignancy: a prospective multicenter trial

Bertis Healthcare0 个研究点目标入组 677 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
677

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
18?(Year) 至 o Limit(—)
性别
Female

入选标准

  • Patients with lesions of BI-RADS category C4b or higher identified through mammography or ultrasound.
  • -Women over 19
  • Patients with no history of other cancers, including breast cancer
  • Patients who voluntarily decided to participate in this clinical study and signed written informed consent
  • Patients in BI-RADS category C1-2

排除标准

  • -Patients with recurrent breast cancer
  • Patients diagnosed with cancer in other organs within 5 years
  • -Patients with other cancers identified by metastases
  • -General condition that prevents you from understanding and submitting consent

研究者

发起方
Bertis Healthcare

相似试验

Multi-protein Assessment using Serum to deTermine... | 临床试验